What is Mesa Laboratories, Inc. Quarterly Revenue?

Mesa Laboratories, Inc. Quarterly Revenue Mesa Laboratories Inc Jun-2026 Quarterly Revenue is $60 Million which is growth of 1.0% YoY.

What is Mesa Laboratories, Inc. Quarterly Net Profit?

Mesa Laboratories, Inc. Quarterly Net Profit Mesa Laboratories Inc Jun-2026 Quarterly Net Profit is $3 Million which is growth of -40.3% YoY.

What is Mesa Laboratories, Inc. Annual Revenue?

Mesa Laboratories, Inc. Annual Revenue Mesa Laboratories Inc Mar-2026 Annual Revenue is $249 Million which is growth of 3.4% YoY.

What is Mesa Laboratories, Inc. Annual Net Profit?

Mesa Laboratories, Inc. Annual Net Profit Mesa Laboratories Inc Mar-2026 Annual Net Profit is $7 Million which is growth of 440.0% YoY.

What is Mesa Laboratories, Inc. Total Shareholders Fund?

Mesa Laboratories, Inc. Total Shareholders Fund Mesa Laboratories Inc Mar-2026 Total Shareholders Fund is $186 Million which is growth of 16.5% YoY.

What is Mesa Laboratories, Inc. Total Assets?

Mesa Laboratories, Inc. Total Assets Mesa Laboratories Inc Mar-2026 Total Assets is $428 Million which is growth of -1.3% YoY.

What is Mesa Laboratories, Inc. Book Value Per Share?

Mesa Laboratories, Inc. Book Value Per Share Mesa Laboratories Inc Book Value Per Share is $34 which is growth of 15.1% YoY.

What is Mesa Laboratories, Inc. ROE?

Mesa Laboratories, Inc. ROE Mesa Laboratories Inc ROE is 4% which is growth of 5.2% YoY.

What is Mesa Laboratories, Inc. Cash From Operating Activity?

Mesa Laboratories, Inc. Cash From Operating Activity Mesa Laboratories Inc Mar-2026 Cash From Operating Activity is $43 Million which is growth of -8.5% YoY.

What is Mesa Laboratories, Inc. Net Cash Flow?

Mesa Laboratories, Inc. Net Cash Flow Mesa Laboratories Inc Mar-2026 Net Cash Flow is $-2 Million which is growth of -3.3% YoY.

Mesa Laboratories, Inc.

XNAS: MLAB

Strong Performer, Getting Expensive

Download real time

-1.40(-1.10%)

87.18% Gain from 52W Low

79,066

XNAS Volume

XNAS 14 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Dividend

Mesa Laboratories Inc has an upcoming dividend of $0.160 per share due on 30 Nov 2026See details

Mesa Laboratories Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Mesa Laboratories Inc share price target, revenues, EPS, net income and more

Mesa Laboratories Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Mesa Laboratories Inc Jun-2026 Quarterly Revenue is $60 Million which is growth of 1.0% YoY.
NEGATIVE
Quarterly Net Profit Mesa Laboratories Inc Jun-2026 Quarterly Net Profit is $3 Million which is growth of -40.3% YoY.

Mesa Laboratories, Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	60.1	63.7	65.1	60.7	59.5	62.1	62.8	57.8	58.2	58.9	53.5	53.2	50.6
CostOfRevenue_Q Cost Of Rev.	21.1	21.5	23.3	23.4	22.6	23.7	23.1	22.4	20.9	22.4	20.1	21.1	19.5
GrossProfit_Q Gross Profit	39	42.2	41.8	37.3	36.9	38.4	39.8	35.5	37.3	36.6	33.4	32.1	31.2
OEXPNS_Q Operating Exp. ⌄	32	39.5	33.8	32.6	33.9	36.9	34	32	31.7	33.3	33.5	32.2	31.9
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	27.3	34.2	28.8	27.6	28.9	31.9	28.9	27.3	26.9	28.1	29.2	27.2	27
ResearchAndDevlopmentExpenses_Q RnD Exp.	4.7	5.3	5	5.1	5	5.1	5.1	4.6	4.7	5.2	4.3	5	4.8
OP_Q Operating Profit	7	2.8	8	4.7	3.1	1.5	5.8	3.5	5.6	3.3	-0.1	-0.1	-0.7
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-2.4	-2.6	-3	-2.9	-2.2	-2.5	-2.8	-3	-2.8	-1.9	-1.9	-0.9	-1.1
Others_Q Other Interest Earned	-	-	-	-	-	-	-	-	-	-	-	-	-
IntExpNonOperating_Q Interest Exp. Non Operating	2.4	2.6	3	2.9	2.2	2.5	2.8	3	2.8	1.9	1.9	0.9	1.1
PBT_Q Profit Before Tax	4.4	-1.6	4.6	2	7	0.5	-2.2	3.8	3.9	-275.3	2	-1.3	-0.9
TAX_Q Tax	1.5	2.5	1	-0.5	2.3	7.6	-0.5	0.4	0.5	-20.8	-0.2	-0.1	-0.4
NICommonStockholders_Q Net Income Common Stockholders ⌄	2.8	-4.1	3.6	2.5	4.7	-7.1	-1.7	3.4	3.4	-254.6	2.1	-1.2	-0.6
NP_Q Net Profit	2.8	-4.1	3.6	2.5	4.7	-7.1	-1.7	3.4	3.4	-254.6	2.1	-1.2	-0.6
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	2.8	-4.1	3.6	2.5	4.7	-7.1	-1.7	3.4	3.4	-254.6	2.1	-1.2	-0.6
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	2.8	-4.1	3.6	2.5	4.7	-7.1	-1.7	3.4	3.4	-254.6	2.1	-1.2	-0.6
EPS_Q Basic EPS	0.5	-0.8	0.7	0.5	0.9	-1.3	-0.3	0.6	0.6	-47.2	0.4	-0.2	-0.1
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.5	-0.8	0.7	2.6	2.3	-1.3	-0.3	0.6	0.1	-47.2	0.4	1.9	1.8
SHARE_Q Number Of Shares End	5.7	5.5	5.5	5.5	5.5	5.4	5.4	5.4	5.4	5.4	5.4	5.4	5.4
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	2.8	-4.1	3.6	2.5	4.7	-7.1	-1.7	3.4	3.4	-254.6	2.1	-1.2	-0.6
NormalizedIncome_Q Normalized Income	4.6	1.2	6.5	5.4	12.9	-4.6	1	6.9	3.2	13.7	4.5	1.7	1.8
InterestIncome_Q Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-
INT_Q Interest	2.4	2.6	3	2.9	2.2	2.5	2.8	3	2.8	1.9	1.9	0.9	1.1
NetInterestIncome_Q Net Interest Income	-2.4	-2.6	-3	-2.9	-2.2	-2.5	-2.8	-3	-2.8	-1.9	-1.9	-0.9	-1.1
EBIT_Q EBIT	6.7	1	7.6	4.9	9.2	3	0.6	6.8	6.8	-273.4	3.8	-0.4	0.1
EBITDA_Q EBITDA	12.4	6.8	13.4	10.7	15.2	10.5	6.1	12.9	12.2	-267.2	12.9	7.7	8.2
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	21.1	21.5	23.3	23.4	22.6	23.7	23.1	22.4	20.9	22.4	20.1	21.1	19.5
ReconciledDepreciation_Q Reconciled Depr.	5.6	5.8	5.7	5.9	6	7.5	5.5	6.1	5.5	6.3	9.1	8.1	8.1
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	2.8	-4.1	3.6	2.5	4.7	-7.1	-1.7	3.4	3.4	-254.6	2.1	-1.2	-0.6
NormalizedEBITDA_Q Normalized EBITDA	12.4	6.8	13.4	10.7	15.2	10.5	6.1	12.9	9	-267.2	12.9	7.7	8.2

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Mesa Laboratories Inc competitor comparison and performance snapshot within industry

Mesa Laboratories Inc annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Mesa Laboratories Inc Mar-2026 Annual Revenue is $249 Million which is growth of 3.4% YoY.
POSITIVE
Annual Net Profit Mesa Laboratories Inc Mar-2026 Annual Net Profit is $7 Million which is growth of 440.0% YoY.

Mesa Laboratories, Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	4.4%	13.2%		249.1	241	216.2	219.1	184.3	133.9	117.7	103.1	96.2	93.7	84.7
TotalOperatingRevenues_A Operating Rev. Ann.	4.4%	13.2%	249.7	249.1	241	216.2	219.1	184.3	133.9	117.7	103.1	96.2	93.7	84.7
CostOfRevenue_A Cost Of Rev. Ann.	2.1%	14.2%	89.4	90.9	90.1	82.9	85.4	75.3	46.9	52.8	42.2	41.6	40.4	33.3
GrossProfit_A Gross Profit Ann.	5.8%	12.7%	160.3	158.3	150.9	133.3	133.7	109.1	87	64.9	60.9	54.6	53.2	51.4
OEXPNS_A Operating Exp. Ann.	2.3%	13.4%	137.9	139.8	134.5	130.8	130.4	104.4	74.6	57.1	43.1	38.6	36.9	35.1
OP_A Operating Profit Ann.	77.6%	8.2%	22.5	18.5	16.3	2.5	3.3	4.7	12.5	7.8	17.9	16	16.3	16.3
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-10.9	-10.7	-11.9	-5.7	-4.8	-3.9	-7.9	-4.5	-	-	-	-
Others_A Other Interest Earned Ann.	-	-		-	-	-	-	-	0.1	1	-	-	-	-
IntExpNonOperating_A Interest Exp. Non Operating Ann.	30.6%	6%	10.9	10.7	11.9	5.7	4.8	3.9	8	5.5	-	-	-	-
OtherExpenses_A Other Exp. Ann.	56.3%	-		4.2	1.5	-272.4	1.1	2.8	-2.2	0.1	-9.2	-15.7	-2	-0.8
PBT_A PBT Ann.	-	39.2%	9.4	12	6	-275.7	-0.4	3.6	2.3	3.4	8.6	0.3	14.3	15.6
TAX_A Tax Ann.	-	-	4.6	5.3	7.9	-21.4	-1.3	1.7	-1	2.1	1.1	3.3	3.1	4.4
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	95.3%	15.2%	4.8	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
NP_A Net Profit Ann.	95.3%	15.2%	4.8	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	95.3%	15.2%	4.8	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	95.3%	15.2%	4.8	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
EPS_A EPS Ann.	81.7%	11.4%		1.2	-0.4	-47.2	0.2	0.4	0.7	0.3	2	-0.8	3	3.1
DilutedEPS_A Diluted EPS Ann.	81.7%	14.9%		1.2	-0.4	-47.2	0.2	0.4	0.6	0.3	1.9	-0.8	2.9	3
SHARE_Q Number Of Shares End	0.6%	1.5%		5.5	5.4	5.4	5.4	5.3	5.1	4.4	3.8	3.8	3.7	3.6
TotalExpenses_A Total Exp. Ann.	2.2%	13.7%		230.6	224.6	213.7	215.8	179.6	121.5	109.8	85.3	80.2	77.4	68.3
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	95.3%	15.2%	4.8	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
NormalizedIncome_A Normalized Income Ann.	24.4%	15.5%	17.8	20.8	6.1	139.5	10.8	10.9	10.1	5.7	18.4	11.6	16.2	15.3
InterestIncome_A Interest Income Ann.	-	-		-	-	-	-	-	0.1	1	-	-	-	-
INT_A Interest Ann.	30.6%	6%	10.9	10.7	11.9	5.7	4.8	3.9	8	5.5	-	-	-	-
EBITDA_A EBITDA Ann.	6.4%	10.5%	43.2	46	42.4	-238.4	38.2	32.5	27.9	21	18.1	9.8	23	22.7
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	2.1%	14.2%	89.4	90.9	90.1	82.9	85.4	75.3	46.9	52.8	42.2	41.6	40.4	33.3
ReconciledDepreciation_A Reconciled Depr. Ann.	-11.7%	5.7%	23	23.3	24.5	31.6	33.8	25.1	17.7	13	9.4	9.5	8.7	7.2
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	95.3%	15.2%	4.8	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
NormalizedEBITDA_A Normalized EBITDA Ann.	6.4%	10.4%	43.2	46	39.5	36.2	38.2	32.5	28.1	22.3	35.4	39.3	25.1	23.5

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

3.4%

2Y CAGR

7.3%

3Y CAGR

4.4%

5Y CAGR

13.2%

7Y CAGR

13.4%

10Y CAGR

11.4%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

3Y CAGR

95.3%

5Y CAGR

15.2%

7Y CAGR

-1.6%

10Y CAGR

-5%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

3.9%

2Y CAGR

3.4%

3Y CAGR

2.3%

5Y CAGR

13.4%

7Y CAGR

18.3%

10Y CAGR

14.8%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Mesa Laboratories Inc balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Mesa Laboratories Inc Mar-2026 Total Shareholders Fund is $186 Million which is growth of 16.5% YoY.
NEGATIVE
Total Assets Mesa Laboratories Inc Mar-2026 Total Assets is $428 Million which is growth of -1.3% YoY.

Mesa Laboratories, Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TA_A Total Assets Ann. ⌄	-13.5%	-6.6%	427.8	433.4	446.8	661.8	707.4	601.5	420.2	156.8	164.1	171.7	160.8
CA_A Total Current Assets Ann.	-3.7%	-18.9%	106.3	102.7	109.4	119	124.3	303.8	122.8	33.6	32	35.8	37.2
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	-6.5%	-36.7%	26.9	27.3	28.2	32.9	49.4	263.9	81.4	10.2	5.5	5.8	5.7
Receivables_A Change In Account Receivables Ann.	1.2%	13.1%	44.1	42	39.1	42.6	41.2	23.8	21.1	12.5	14.3	14.3	15.3
Inventories_A Inventories Ann.	-8.6%	18.7%	26.4	25.4	32.7	34.6	24.6	11.2	14.2	6.8	9.2	13.9	14
OtherCurrentAssets_A Other Current Assets Ann.	-26%	-2.6%	3.6	2.9	3.3	8.9	9.1	4.1	4.1	1.6	0.8	1.8	0.9
TotalNonCurrentAssets_A Total Non Current Assets Ann.	-16%	1.6%	321.5	330.7	337.4	542.9	583.1	297.7	297.4	123.1	132.1	136	123.6
NetPPE_A Net PPE Ann.	2.8%	6.8%	30.6	32.3	31.8	28.2	28.6	22	22.1	22.2	23.6	26	16.6
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	22.7%	50.3%	19.2	18.3	10.5	10.4	11.8	2.5	2.5	-	-	-	-
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	-3.5%	4.3%	241.5	273.5	301.4	268.4	313.6	195.3	200.2	45.5	64.7	73.9	76.1
CL_A Total Current Liabilities Ann.	12.6%	13.7%	61.9	164	44.3	43.4	48.1	32.6	26	23.7	17.3	16.6	24
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	15.2%	10.7%	37.9	44.7	25.9	24.8	30.7	22.8	17.6	14.2	11	10	13.2
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	47.5%	56.2%	9.3	104.6	3	2.9	2.8	1	1.1	2.1	1.6	1.1	3
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-2.2%	10.8%	14.7	14.7	15.5	15.7	14.6	8.8	6.8	4	3.9	4.1	3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	0.6	3.3	0.7	1.3	4.8
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	-7.2%	2%	179.6	109.6	257.1	225	265.5	162.7	174.2	21.8	47.5	57.3	52.1
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-7.3%	0%	145.9	76.9	221.7	183.3	218.4	145.7	140.3	20.6	44.6	53.7	42.3
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-22.1%	-14.4%	186.2	159.8	145.4	393.5	393.8	406.2	220	111.3	99.4	97.8	84.7
EQCAP_A Equity Share Capital Ann.	-22.1%	-14.4%	186.2	159.8	145.4	393.5	393.8	406.2	220	111.3	99.4	97.8	84.7
CapitalStock_A Capital Stock Ann.	4.2%	3.4%	375.4	358.5	343.6	332.1	313.5	317.7	158	39.8	30.5	25.9	21
RetainedEarnings_A Retained Earnings Ann.	-	-	-185.8	-188.9	-183.5	74.2	76.7	72.5	71.9	73.3	68.3	73.7	64.8
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-3.4	-9.8	-14.8	-12.8	3.7	16.1	-9.9	-1.8	0.6	-1.8	-1.2
TotalCapitalization_A Total Capitalization Ann.	-16.8%	-9.7%	332.1	236.7	367.1	576.8	612.2	551.9	360.3	131.9	144	151.5	126.9
TangibleAssets_A Tangible Assets Ann.	-	-	-84	-118.8	-148.5	-109.8	-147.5	133.6	-41.4	11.7	-9	-12.1	-22.3
WC_A Working Capital Ann.	-16.3%	-30.4%	44.4	-61.3	65	75.6	76.3	271.2	96.8	10	14.7	19.2	13.2
InvestedCapital_A Invested Capital Ann.	-16.3%	-9.4%	337.7	337.8	367.1	576.8	612.2	551.9	360.3	134.1	145.6	152.6	129.9
TangibleBookValue_A Tangible Book Value Ann.	-	-	-84	-118.8	-148.5	-109.8	-147.5	133.7	-41.4	11.7	-9	-12.1	-22.3
Borrowings_A Borrowings Ann.	-5.9%	1.1%	155.2	181.5	224.7	186.1	221.1	146.7	141.4	22.7	46.3	54.8	45.3
NetDebt_A Net Debt Ann.	-6.1%	-	124.6	150.6	193.5	150.4	169	-	58.9	12.6	40.8	49	39.6
ShareIssued_A Share Issued Ann.	0.6%	1.5%	5.5	5.5	5.4	5.4	5.3	5.1	4.4	3.9	3.8	3.7	3.6
SHARE_Q Number Of Shares End	0.6%	1.5%	5.5	5.4	5.4	5.4	5.3	5.1	4.4	3.8	3.8	3.7	3.6

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-1.3%

2Y CAGR

-2.1%

3Y CAGR

-13.5%

5Y CAGR

-6.6%

7Y CAGR

15.4%

10Y CAGR

10.3%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

-62.3%

2Y CAGR

18.2%

3Y CAGR

12.6%

5Y CAGR

13.7%

7Y CAGR

14.7%

10Y CAGR

9.9%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

16.5%

2Y CAGR

13.2%

3Y CAGR

-22.1%

5Y CAGR

-14.4%

7Y CAGR

7.6%

10Y CAGR

8.2%

Total ShareHolders Funds Annual growth is higher than historical averages.

Mesa Laboratories Inc ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Mesa Laboratories Inc Book Value Per Share is $34 which is growth of 15.1% YoY.
POSITIVE
ROE Mesa Laboratories Inc ROE is 4% which is growth of 5.2% YoY.

Mesa Laboratories, Inc., Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
ROA_A RoA Ann. %	123.4%	19.5%	1.56%	-0.45%	-45.87%	0.14%	0.29%	0.64%	0.47%	4.66%	-1.76%	6.73%	8.03%
ROE_A ROE Ann. %	152.9%	29.9%	3.88%	-1.29%	-94.36%	0.24%	0.47%	1.05%	0.81%	7.10%	-3.00%	12.26%	14.12%
ROIC_Q ROIC %	-	-	-0.7	-1.5	-50.1	0.3	-0.1	1	-0.1	1	2.9	2.4	3.7
OPMPCT_A OPM Ann. %	69.7%	-4.4%	7.43%	6.78%	1.14%	1.52%	2.55%	9.29%	6.66%	17.31%	16.64%	17.42%	19.28%
NBTO_A Inventory Turnover Ratio Ann.	6.5%	-1.1%	3.5	3.1	2.5	2.9	4.2	3.7	5	5.3	3.6	2.9	2.5
ASETTO_A Asset Turnover Ann. %	26%	14.9%	0.6	0.6	0.4	0.3	0.3	0.3	0.4	0.6	0.6	0.6	0.6
WCTO_A Working Capital Turnover Ann.	24.5%	62.1%	5.6	-3.9	3.3	2.9	2.4	0.5	1.2	10.4	6.5	4.9	6.4
QuickRatio_A Quick Ratio Ann.	-11%	-32.9%	1.2	0.4	1.5	1.7	1.9	8.8	3.9	1	1.1	1.2	0.9
CRATIO_A Current Ratio Ann.	-14.3%	-28.8%	1.7	0.6	2.5	2.7	2.6	9.3	4.7	1.4	1.9	2.2	1.6
IC_A Interest Coverage Ratio Ann.	32.6%	10.1%	2.1	1.5	-47.4	0.9	1.9	1.3	1.6	-	-	-	-
LTDE_A LT Debt To Equity Ann.	17%	14.9%	0.8	0.5	1.5	0.5	0.6	0.4	0.6	0.2	0.5	0.6	0.5

*All financials are in USD Million and price data in USD

Add metric to table

Search...

ROE Ann. %

3Y CAGR

152.9%

5Y CAGR

29.9%

7Y CAGR

-8.3%

10Y CAGR

-12.1%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

3Y CAGR

123.4%

5Y CAGR

19.5%

7Y CAGR

-14.5%

10Y CAGR

-15.1%

RoA Annual % is growing faster than historical averages.

Current Ratio Ann.

1Y CHG

183.3%

2Y CAGR

-17.5%

3Y CAGR

-14.3%

5Y CAGR

-28.8%

7Y CAGR

2.8%

10Y CAGR

0.6%

Current Ratio Annual growth is higher than historical averages.

Mesa Laboratories Inc cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Mesa Laboratories Inc Mar-2026 Cash From Operating Activity is $43 Million which is growth of -8.5% YoY.
NEGATIVE
Net Cash Flow Mesa Laboratories Inc Mar-2026 Net Cash Flow is $-2 Million which is growth of -3.3% YoY.

Mesa Laboratories, Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	15.2%	2.9%	42.8	46.8	44.1	28	39.2	37.1	26.6	30.6	24.8	7.8	16.9
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	95.3%	15.2%	6.7	-2	-254.3	0.9	1.9	3.3	1.4	7.5	-3	11.2	11.2
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-11.7%	5.7%	23.3	24.5	31.6	33.8	25.1	17.7	13	9.4	9.5	8.7	7.2
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-11.7%	5.7%	23.3	24.5	31.6	33.8	25.1	17.7	13	9.4	9.5	8.7	7.2
DeferredTax_A Deferred Tax Ann.	-	-	-1.3	-0.1	-28.4	-3.5	0.1	-3.5	-2	-2.5	-2.7	-0.6	-0.8
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-1.3	-0.1	-28.4	-3.5	0.1	-3.5	-2	-2.5	-2.7	-0.6	-0.8
EmployeesStockOptions_A ESOPs Ann.	12.7%	14%	17.9	13.1	11.9	12.5	11.4	9.3	5.5	4.2	1.7	1.4	1.3
OtherNonCashItems_A Other Non Cash Items Ann.	0%	-23.9%	1.3	7.2	2.8	1.3	8	5.1	11.8	0	0.4	-	-
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-5	6.9	6	-17.1	-7.2	5.3	-3.1	7.9	3.2	-13	-2
ChangeInReceivables_A Change In Receivables Ann.	-	-	-3.2	-2.9	4.9	-2.1	-6.8	-0.7	-1.7	1.6	0.7	1	-2
ChangeInInventory_A Change In Inventory Ann.	-	-	-4.4	1.2	2.6	-10.2	-1	0.9	0.4	2.6	2.3	0.3	-1.2
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-	26.9%	2.3	9.1	-1.3	-4.9	1.6	0.7	-2.2	6.6	0.6	-3.7	2.7
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-0.9	-9.6	-2.1
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-0.3	-0.9	-0.4	0.6	2.6	1.4	0.8	0.1	-0.2	-0.2	0.1
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-3.3	-4.5	-81.3	-9.5	-305.2	-2	-185.6	-3.9	-17.2	-18.4	-31.8
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-3.3	-4.3	-2.6	-4.5	-4.4	-2	-1.5	-1.3	-2.8	-11.6	-7.7
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-3.3	-4.3	-2.6	-4.5	-4.4	-2	-1.5	-1.3	-2.8	-11.6	-7.7
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-			-78.7	-5	-300.8		-184.1	-4.8	-15.5	-6.8	-24.1
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-			-78.7	-5	-300.8		-184.1	-4.8	-15.5	-6.8	-24.1
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
SaleOfInvestment_A Sale Of Investment Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-	-	-	-	-	-	0	2.2	1.1	-	-
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-41.9	-44.5	32.8	-33.3	52.6	146.2	231.3	-21.7	-8.1	10.7	18.6
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-26.8	-42.4	37.5	-36	49		149.5	-23.6	-8.6	9.6	19
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-26.8	-42.4	37.5	-36	49		149.5	-23.6	-8.6	9.6	19
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-	-	-			145.9	85	-	-	-	-
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-	-			145.9	85	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
dividend_1Y_actual Dividend 1year	0%	0%	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6
DividendPerShare_A Dividend Per Share Ann.	0%	-	0.6	0.6	0.6	0.6	0.6	-	0.6	0.6	0.6	0.6	0.6
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-11.6	-1.3	-1.6	-0.9	-0.2	-1	-5.4	-0.7	-	-	-
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-6.5%	-36.7%	26.9	27.3	28.2	32.9	49.4	263.9	81.4	10.2	5.5	5.8	5.7
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-	-2.3	-2.2	-4.3	-14.8	-213.4	181.3	72.3	5	-0.5	0.1	3.7
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-17.9%	-19.6%	27.3	28.2	32.9	49.4	263.9	81.4	10.2	5.5	5.8	5.7	2
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	10.7%	6.3%	1.9	5.7	4.6	1.4	3.1	1.4	-2.6	5.9	4.6	5.6	4
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	41.9%	33%	10	11.1	4.7	3.5	2.8	2.4	-1.6	1.6	2	1.4	0.9
CapitalExpenditure_A Capex Ann.	-	-	-3.3	-4.5	-2.6	-4.5	-4.4	-2	-1.5	-1.3	-2.8	-11.6	-7.7
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-	-			145.9	85	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	-	-	107.5	73.5	71		70		172.5	2	11	66.6	25
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-134.3	-115.8	-33.5	-36	-21		-23	-25.6	-19.6	-57	-6
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
FreeCashFlow_A Free Cash Flow Ann.	19.2%	2.4%	39.6	42.3	41.6	23.4	34.8	35.1	25.1	29.3	22	-3.9	9.2

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-8.5%

2Y CAGR

-1.5%

3Y CAGR

15.2%

5Y CAGR

2.9%

7Y CAGR

4.9%

10Y CAGR

9.7%

Cash from Operating Activity Annual is falling faster than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

87.18% Gain from 52W Low

Mesa Laboratories Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Mesa Laboratories Inc - Forecaster

Forecaster Analyst Estimates for Mesa Laboratories Inc share price target, revenues, EPS, net income and more

Mesa Laboratories Inc - Earnings Report - Quarterly Results

Mesa Laboratories Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Mesa Laboratories Inc Jun-2026 Quarterly Revenue is $60 Million which is growth of 1.0% YoY.

Quarterly Net Profit Mesa Laboratories Inc Jun-2026 Quarterly Net Profit is $3 Million which is growth of -40.3% YoY.

Mesa Laboratories Inc - Competitors/Peers

Mesa Laboratories Inc competitor comparison and performance snapshot within industry

Mesa Laboratories Inc - Earnings Report - Annual Results

Mesa Laboratories Inc annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Mesa Laboratories Inc Mar-2026 Annual Revenue is $249 Million which is growth of 3.4% YoY.

Annual Net Profit Mesa Laboratories Inc Mar-2026 Annual Net Profit is $7 Million which is growth of 440.0% YoY.

Mesa Laboratories Inc - Balance Sheet

Mesa Laboratories Inc balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Mesa Laboratories Inc Mar-2026 Total Shareholders Fund is $186 Million which is growth of 16.5% YoY.

Total Assets Mesa Laboratories Inc Mar-2026 Total Assets is $428 Million which is growth of -1.3% YoY.

Mesa Laboratories Inc - Ratios

Mesa Laboratories Inc ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Book Value Per Share Mesa Laboratories Inc Book Value Per Share is $34 which is growth of 15.1% YoY.

ROE Mesa Laboratories Inc ROE is 4% which is growth of 5.2% YoY.

Mesa Laboratories Inc - Cash Flow

Mesa Laboratories Inc cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Cash From Operating Activity Mesa Laboratories Inc Mar-2026 Cash From Operating Activity is $43 Million which is growth of -8.5% YoY.

Net Cash Flow Mesa Laboratories Inc Mar-2026 Net Cash Flow is $-2 Million which is growth of -3.3% YoY.